Moreover, iBMDMs treated with IFN-α prior to orthotopic co-injection with PDAC tumor cells markedly decreased the infiltration of CD4+/CD8+ T cells and increased the percentage of exhausted T cells in the TME (168). The gene discussed is IFNA2; the disease is neoplasm.